GLP-1 (glucagon-like peptide-1) is a natural gut hormone, and "GLP-1 medications" or "GLP-1 receptor agonists" is the broader drug class built to mimic it. Ozempic is one specific brand in that class: a once-weekly injection containing the active ingredient semaglutide, made by Novo Nordisk, and FDA-approved for type 2 diabetes, not weight loss. Wegovy is the same active ingredient at a higher dose, approved specifically for chronic weight management. Rybelsus is the oral version of semaglutide, also approved for type 2 diabetes. So: GLP-1 is the category, Ozempic is one product in it.
Key takeaways
- GLP-1 is both a hormone and the name of a drug class; Ozempic is one brand within that class.
- Ozempic contains semaglutide and is FDA-approved for type 2 diabetes, not weight loss.
- Wegovy is the same active ingredient at a higher dose, approved for chronic weight management.
- Rybelsus is oral semaglutide, also approved for type 2 diabetes.
GLP-1 the class vs. Ozempic the brand
GLP-1 refers to two related things. First, it's the name of a hormone, glucagon-like peptide-1, that your gut naturally releases after eating to help regulate blood sugar and appetite. Second, "GLP-1" is shorthand for the broader class of medications, formally called GLP-1 receptor agonists, engineered to activate the same receptor as that hormone but last far longer in the body. Our what is GLP-1 guide covers the hormone and mechanism in more depth.
Ozempic is one specific medication inside that class. It's a brand name, not a chemical name, for the active ingredient semaglutide, manufactured by Novo Nordisk and delivered as a once-weekly injection. Other drugs in the same broad class include liraglutide (Saxenda, Victoza), dulaglutide (Trulicity), and dual or triple agonists like tirzepatide (Mounjaro, Zepbound) that also act on additional hormone receptors. Saying "GLP-1" when you mean "Ozempic" is a bit like saying "SUV" when you mean one specific car model, Ozempic is a member of the GLP-1 category, not a synonym for it.
| Term | What it actually refers to |
|---|---|
| GLP-1 | A natural gut hormone, and shorthand for the drug class that mimics it (GLP-1 receptor agonists) |
| Ozempic | Brand name for semaglutide injection, approved for type 2 diabetes |
| Wegovy | Brand name for semaglutide injection at a higher dose, approved for chronic weight management |
| Rybelsus | Brand name for oral (pill) semaglutide, approved for type 2 diabetes |
| Semaglutide | The active ingredient shared by Ozempic, Wegovy, and Rybelsus |
What is Ozempic actually approved for?
Ozempic's FDA-approved use is to improve blood sugar control, alongside diet and exercise, in adults with type 2 diabetes. It also carries FDA-approved indications to reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease, and to reduce the risk of kidney function decline in adults with type 2 diabetes and chronic kidney disease. It is not FDA-approved for weight loss on its own, even though weight loss is a common effect people notice while taking it for diabetes. Some clinicians prescribe it off-label for weight management in people without diabetes; this article does not recommend or encourage off-label use, and any decision about that belongs between you and your prescriber.
If weight management is the primary goal, Wegovy is the version of semaglutide that's actually approved and dosed for that purpose, reaching a higher maximum dose (2.4 mg weekly) than Ozempic's maximum of 2 mg weekly. Our Ozempic vs Wegovy comparison goes through the dosing, cost, and coverage differences between the two in detail.
Ozempic vs. Wegovy vs. Rybelsus
All three are Novo Nordisk products built on the same active ingredient, semaglutide, but they differ in approved use, dose, and form:
- Ozempic, once-weekly injection, approved for type 2 diabetes, maximum dose 2 mg weekly.
- Wegovy, once-weekly injection, approved for chronic weight management, maximum dose 2.4 mg weekly.
- Rybelsus, daily oral tablet, approved for type 2 diabetes, the only pill form of semaglutide among the three.
Because they share an active ingredient, some people on one product notice their doctor discussing another, for example switching from Ozempic to Wegovy if the goal shifts primarily toward weight management, or from injections to Rybelsus for people who prefer a pill. Any switch between these products should go through your prescriber, since dosing schedules and titration differ between them.
Why the terms get mixed up
Ozempic became one of the most searched and talked-about medications of the past several years, partly because of its high-profile use for weight loss even outside its approved indication. That visibility means "Ozempic" is sometimes used online as a catch-all word for any GLP-1 medication, similar to how some people say "Kleenex" for any facial tissue. It's a useful shorthand in casual conversation, but it can cause real confusion when the specifics matter, for example when comparing side effects, costs, or approved uses, since Ozempic, Wegovy, Mounjaro, Zepbound, and other GLP-1 or dual-agonist drugs are not interchangeable. Our full medications guide breaks down each individual drug in the class.
Watch for "GLP-1" used to market unapproved products
Because "GLP-1" has become such a widely searched term, it also shows up in marketing for products that are not FDA-approved semaglutide or tirzepatide at all, things like compounded versions sold by some online sellers, "research peptides," or gummies, drops, and patches claiming GLP-1-like effects. None of these are Ozempic, Wegovy, or any other FDA-approved GLP-1 medication, even when the marketing borrows the terminology or implies similarity. Compounded semaglutide and tirzepatide are not FDA-approved products, meaning they haven't gone through the same manufacturing, purity, and safety review as brand-name Ozempic or Wegovy, and supplements marketed as "GLP-1 boosters" have not been shown to work the way prescription GLP-1 receptor agonists do.
If a product is genuinely Ozempic, Wegovy, or another approved GLP-1 medication, it requires a prescription from a licensed clinician and comes through a licensed pharmacy. Being wary of "no prescription needed" or "same as Ozempic" language on unfamiliar sellers is a reasonable default, and any questions about a specific product's legitimacy are worth raising directly with a pharmacist or your prescriber.
Frequently asked questions
Is GLP-1 the same as Ozempic?
No. GLP-1 is a hormone your gut makes and also the name of the drug class (GLP-1 receptor agonists). Ozempic is one specific brand-name medication in that class, containing the active ingredient semaglutide, approved for type 2 diabetes.
What is Ozempic in the GLP-1 class?
Ozempic is a GLP-1 receptor agonist, a once-weekly injection containing semaglutide, made by Novo Nordisk. It is FDA-approved to improve blood sugar control in adults with type 2 diabetes and to reduce cardiovascular and certain kidney-related risks in that population.
Is Ozempic approved for weight loss?
No. Ozempic is not FDA-approved for weight loss. Wegovy, a higher-dose version of the same active ingredient (semaglutide) from the same manufacturer, is the version FDA-approved for chronic weight management. Some clinicians prescribe Ozempic off-label for weight loss, which this article does not recommend or encourage.
What is the difference between Ozempic and Wegovy?
Ozempic and Wegovy contain the same active ingredient, semaglutide, made by the same manufacturer. Ozempic is approved for type 2 diabetes with a maximum dose of 2 mg weekly. Wegovy is approved for chronic weight management with a higher maximum dose of 2.4 mg weekly.
Sources & further reading
- U.S. Food & Drug Administration, Ozempic (semaglutide) prescribing information and approval history.
- U.S. Food & Drug Administration, Wegovy (semaglutide) prescribing information and approval history.
- U.S. Food & Drug Administration, Rybelsus (oral semaglutide) prescribing information.